

clinical supplies
Avoid the risks
For testing in man, it is crucial to have a product that is robustly formulated with maximum bioavailability. Physical or chemical Stability changes of the dosage form can cause costly damage to development programs.
Robust formulations
For a formulation to be successful, it simply must be robust. Our expertise in developing and characterizing formulations can avoid the risks of developing unreliable formulations which may crystallize upon storage.
cGMP manufacturing
In close cooperation with the client's study planning, cGMP supplies suitable for use in clinical trials can be manufactured and prepared for the studies. Special attention is paid to maintaining cGMP standards during the entire process. Careful coordination with the client and manufacturing site ensures flawless execution of the clinical supply planning.
BioPharm America
Atlanta, Georgia
September 9-10, 2008
AAPS
Atlanta, Georgia
November 16-20, 2008
BIO-Europe
Mannheim/Heidelberg, Germany
November 17-19, 2008